Searched for
BIOCON BIOLOGICS INVESTMENT
With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...08 Apr, 2026, 12.38 AM IST- Biocon Biologics refinances 1.1 billion debt through US dollar bonds and new syndicated facilityThe bonds will be issued by Biocon Biologics Global plc which is a wholly owned subsidiary of BBL and will be backed by a strong security p...03 Oct, 2024, 09.24 AM IST
- Competition Commission of India clears Kotak-Biocon Biologics dealThe investment will help Biocon Biologics' acquisition of the biosimilars business of its partner Viatris.11 Aug, 2023, 06.53 PM IST
- Biocon Biologics may raise additional equity of $300 million in FY24 to pare debtBiocon Biologics plans to raise a further $300m by the end of FY24 in order to reduce its net debt, which peaked at $1.9bn in December 2022...25 May, 2023, 02.57 PM IST
- Serum Institute to double investment in Biocon Biologics to $300 millionSerum Institute of Life Sciences (SILS) has converted a $150 million loan into equity, increasing its investment in Biocon Biologics. This ...25 Apr, 2023, 08.27 PM IST
- India's Serum to double investment in Biocon's unit to $300 mlnSerum Institute of Life Sciences is a unit of Serum Institute of India, the world's biggest vaccine maker. Under new terms of the alliance,...25 Apr, 2023, 09.55 AM IST
- Biocon completes $3.34 billion acquisition of Viatris's biosimilar businessTo fund the upfront payment, Biocon Biologics has secured $1.2 billion of Sustainability Linked Loan (SLL). The balance has been funded thr...29 Nov, 2022, 07.24 PM IST
- Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar businessThe transaction with US-based Viatris required regulatory approvals from the Reserve Bank of India, Competition Commission of India and the...16 Nov, 2022, 11.04 AM IST
- Biocon gains 2% as arm receives Rs 555 crore equity investment from ADQKiran Mazumdar-Shaw, Executive Chairperson at Biocon in a company filing to BSE said, "We welcome ADQ as our investment partner as we pursu...08 Jan, 2021, 09.45 AM IST
- Abu Dhabi-based ADQ picks up minority stake in Biocon Biologics for $75 millionThe transaction values Biocon Biologics at $4.17 billion, said the company in a press release.07 Jan, 2021, 10.41 PM IST
- Biocon Biologics approves primary equity investment by ADQ worth Rs 555 croreAs per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, val...07 Jan, 2021, 08.21 PM IST
- Biocon Biologics to receive $150 million from Goldman Sachs against convertible debentures“The Board of its (Biocon’s) subsidiary Biocon Biologics has approved a Rs 1,125 Crore ($150 million) capital injection from Goldman Sachs....07 Nov, 2020, 04.28 PM IST
- Tata Capital picks up 0.85% stake in Biocon Biologics for $30 millionPost the completion of this transaction, Biocon will hold a 95.25 per cent stake in Biocon Biologics.31 Jul, 2020, 09.35 AM IST
- Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-ShawIt looks to build a pipeline of 28 biosimilars across global markets in three phases.27 Jan, 2020, 07.41 AM IST
- True North to acquire 2.4% stake in Biocon BiologicsDeal values Biocon Biologics at $3 billion06 Jan, 2020, 07.51 PM IST
- True North buys into Biocon Biologics, deal values firm at around $3.5 billionTrue North has acquired about 3 per cent of Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million, valui...06 Jan, 2020, 08.59 AM IST
- Temasek, TrueNorth-CPPIB seek to invest in Biocon BiologicsEye minority stake in Biocon Biologics; unit may be valued at $4 billion, higher than the market cap of Biocon.21 Aug, 2019, 07.03 PM IST
Load More
